Achieve Life Sciences Inc Hares (NASDAQ:ACHV) Shorts Decreased By 16.05%

Change of 16.05% for Achieve Life Sciences Inc Hares (NASDAQ:ACHV)’s shorted shares was registered. In December was issued ACHV’s total 296,500 shorted shares by FINRA. The 353,200 previous shares are down with 16.05%. With Average volume 56,900, ACHV’s previous position will take 5 days to recover. Achieve Life Sciences Inc Hares’s shorted shares float is 7.04%.

ACHV is reaching $1.45 during the last trading session, after decreased 2.03%.Achieve Life Sciences, Inc. has volume of 241,301 shares. Since December 8, 2017 ACHV has declined 91.20% and is downtrending. The stock underperformed the S&P500 by 106.82%.

Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients.The firm is worth $9.75 million. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer.Last it reported negative earnings.

For more Achieve Life Sciences, Inc. (NASDAQ:ACHV) news announced briefly go to: Benzinga.com, Seekingalpha.com, Benzinga.com, Benzinga.com or Nasdaq.com. The titles are as follows: “Benzinga’s Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma’s Q4 Miss, Sage Inks Deal With Japan’s Shionogi – Benzinga” announced on June 14, 2018, “Premarket Gainers as of 9:05 am (06/26/2018) – Seeking Alpha” on June 26, 2018, “20 Stocks Moving In Friday’s Pre-Market Session – Benzinga” with a publish date: October 12, 2018, “26 Stocks Moving In Friday’s Pre-Market Session – Benzinga” and the last “Mid-Day Market Update: Dow Down Over 200 Points; Affimed Shares Plummet – Nasdaq” with publication date: June 15, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.